À proposConditionsConfidentialitéContact
 
Actualisation
Lung Cancer Considered

Lung Cancer Considered

IASLC
Date de sortie : 2023-02-07
© All rights reserved
Lung Cancer Considered - QR Code
LibreNew
148 épisodes
Audio
Écouter sur Apple Podcasts
LibreNew
148 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2023-02-07
© All rights reserved
L’épisode le plus récent
IASLC - LALCA Highlights

IASLC - LALCA Highlights

The Latin American Conference on Lung Cancer, hel…
Durée : 36:31
Lecture
The Latin American Conference on Lung Cancer, held in Uruguay, wrapped up in late January. To provide a summary of key findings from the meeting, Lung Cancer Considered host Dr. Narjust Florez interviewed two prominent oncologists from South America:
Dr. Clarissa Mathias, Dr. Mathias is a medical oncologist and director of NOB/Oncoclinicas in Brazil. She is a member of the ASCO International Quality Steering Group and Lung cancer committee. Dr. Mathias served on the IASLC board and has led many efforts in thoracic oncology in Brazil and recently hosted an episode of Lung Cancer Considered in Portuguese.
Dr. Carlos Barrios, born in Uruguay but practicing oncologist in Brazil. Dr. Barrios is Director and Principal Investigator of the Oncology Research Center at Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul since 1996, where he has participated in more than 300 clinical research trials during the past 15 years. He is Director of Clinical Research and Oncologist of the Oncoclínicas Group in Porto Alegre. He is Adjunct Assistant Professor of the William Harrington Latin American Program of the University of Miami School of Medicine.
Id. d’épisode : 1000598497061
GUID : tag:soundcloud,2010:tracks/1441174186
Date de publication : 7/2/2023 à 16:30:00

Description

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
Lung Cancer considered is funded in part by AstraZeneca, Bristol Myers Squibb, Lilly Oncology, and Merck KGaA.

Adresse du flux

https://feeds.soundcloud.com/users/soundcloud:users:608921562/sounds.rss

Apple Podcasts : Avis des utilisateurs

Pas d'entrée